Blood and marrow transplantation for sickle cell disease: overcoming barriers to success
- 1 March 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Oncology
- Vol. 21 (2), 158-161
- https://doi.org/10.1097/cco.0b013e328324ba04
Abstract
Purpose of review Sickle cell disease (SCD) is a common health problem in the United States; yet, the only curative therapy, a bone marrow transplant (BMT), is seldom applied. The objective of this report is to review the most recent clinical trials involving blood and BMT for SCD and to discuss novel approaches to overcome the many barriers to successful use of BMT for SCD. Recent findings In select patients, disease-free and overall survival is greater than 80% following matched sibling BMT for SCD. Unfortunately, most patients with SCD do not have a suitable human lymphocyte antigen-matched sibling donor. In an attempt to expand the donor pool, several groups are beginning to explore the use of alternative sources of stem cells such as haploidentical donors and umbilical cord cell blood. Summary The curative potential of BMT in SCD is irrefutable, with outstanding results in children following a myeloablative conditioning regimen and a matched sibling donor transplant. Well tolerated and effective application of alternative sources of stem cells for BMT in SCD could greatly increase the cure rate for this devastating disease.Keywords
This publication has 20 references indexed in Scilit:
- Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseasesBone Marrow Transplantation, 2008
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Response: Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself?Blood, 2008
- Fludarabine-Based Nonmyeloablative Stem Cell Transplantation for Sickle Cell Disease with and without Renal Failure: Clinical Outcome and PharmacokineticsTransplantation and Cellular Therapy, 2007
- Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysisBritish Journal of Haematology, 2007
- Children With Sickle Cell Disease: Growth and Gonadal Function After Hematopoietic Stem Cell TransplantationJournal of Pediatric Hematology/Oncology, 2007
- Matched‐related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant ResearchBritish Journal of Haematology, 2007
- Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemiaBritish Journal of Haematology, 2007
- BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIAThe Lancet, 1988
- Bone-Marrow Transplantation in a Patient with Sickle-Cell AnemiaThe New England Journal of Medicine, 1984